GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies

NACompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

June 10, 2019

Study Completion Date

May 22, 2020

Conditions
Cheek Augmentation
Interventions
DEVICE

GAL1704

new dermal filler

DEVICE

Juvederm Voluma

hyaluronic acid

Trial Locations (15)

10021

Galderma Study Site, New York

10028

Galderma Study Site, New York

10549

Galderma Study Site, Mount Kisco

11137

Galderma Study Site, Miami

21208

Galderma Study Site, Baltimore

29414

Galderma study site, Charleston

33401

Galderma Study Site, West Palm Beach

70115

Galderma Study Site, New Orleans

75254

Galderma Study site, Dallas

77401

Galderma study site, Bellaire

84101

Galderma Study Site, Salt Lake City

90069

Galderma Study site, Los Angeles

92075

Galderma Study Site, Solana Beach

95816

Galderma Study Site, Sacramento

02467

Galderma Study Site, Chestnut Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03700047 - GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies | Biotech Hunter | Biotech Hunter